Cue Biopharma Stock Price on May 14, 2024
| CUE Stock | USD 1.89 0.18 10.53% |
Below is the normalized historical share price chart for Cue Biopharma extending back to January 02, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cue Biopharma stands at 1.89, as last reported on the 21st of May, with the highest price reaching 1.94 and the lowest price hitting 1.74 during the day.
If you're considering investing in Cue Stock, it is important to understand the factors that can impact its price. We consider Cue Biopharma very risky. Cue Biopharma secures Sharpe Ratio (or Efficiency) of 0.0049, which signifies that the company had a 0.0049% return per unit of standard deviation over the last 3 months. We have found twenty-two technical indicators for Cue Biopharma, which you can use to evaluate the volatility of the firm. Please confirm Cue Biopharma's risk adjusted performance of (0), and Mean Deviation of 4.76 to double-check if the risk estimate we provide is consistent with the expected return of 0.0356%.
At present, Cue Biopharma's Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Issuance Of Capital Stock is expected to grow to about 24 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 30 M. . As of May 21, 2024, Price To Sales Ratio is expected to decline to 20.90. In addition to that, Price Earnings Ratio is expected to decline to -2.5. Cue Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 2nd of January 2018 | 200 Day MA 2.337 | 50 Day MA 1.7946 | Beta 1.972 |
Cue |
Sharpe Ratio = 0.0049
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CUE |
Estimated Market Risk
| 7.21 actual daily | 63 63% of assets are less volatile |
Expected Return
| 0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cue Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cue Biopharma by adding Cue Biopharma to a well-diversified portfolio.
Price Book 2.2823 | Enterprise Value Ebitda (1.10) | Price Sales 15.5056 | Shares Float 45.4 M | Wall Street Target Price 9.4 |
Cue Biopharma Main Headline on 14th of May 2024
FDA advises against using Cue Health COVID-19 tests, sends w... by finance.yahoo.com
Agency inspectors found Cue made unauthorized changes to its COVID-19 kits that reduced the reliability of the tests.
Cue Biopharma Valuation on May 14, 2024
It is possible to determine the worth of Cue Biopharma on a given historical date. On May 14, 2024 Cue was worth 1.7 at the beginning of the trading date compared to the closed value of 1.55. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cue Biopharma stock. Still, in general, we apply an absolute valuation method to find Cue Biopharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cue Biopharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cue Biopharma's related companies.
| Open | High | Low | Close | Volume | |
| 1.74 | 1.83 | 1.65 | 1.65 | 98,113 | |
05/14/2024 | 1.70 | 1.74 | 1.54 | 1.55 | 614,521 |
| 1.65 | 1.67 | 1.52 | 1.64 | 263,507 |
| Backtest Cue Biopharma | | | Cue Biopharma History | | | Cue Biopharma Valuation | Previous | Next |
Cue Biopharma Trading Date Momentum on May 14, 2024
| On May 15 2024 Cue Biopharma was traded for 1.64 at the closing time. Highest Cue Biopharma's price during the trading hours was 1.67 and the lowest price during the day was 1.52 . The net volume was 263.5 K. The overall trading history on the 15th of May 2024 contributed to the next trading period price growth. The overall trading delta to the next next day price was 5.81% . The overall trading delta to current price is 18.71% . |
Cue Biopharma Fundamentals Correlations and Trends
By evaluating Cue Biopharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cue Biopharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cue financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Cue Biopharma Stock history
Cue Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cue is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cue Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cue Biopharma stock prices may prove useful in developing a viable investing in Cue Biopharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 45.8 M | 30 M | |
| Net Loss | -47.7 M | -50.1 M |
Cue Biopharma Quarterly Net Working Capital |
|
Cue Biopharma Stock Technical Analysis
Cue Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Cue Biopharma Period Price Range
Low | May 14, 2024
| High |
1.70 | 1.55 |
Cue Biopharma May 21, 2024 Market Strength
Market strength indicators help investors to evaluate how Cue Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cue Biopharma shares will generate the highest return on investment. By undertsting and applying Cue Biopharma stock market strength indicators, traders can identify Cue Biopharma entry and exit signals to maximize returns
| Accumulation Distribution | 70634.6 | |||
| Daily Balance Of Power | (0.75) | |||
| Rate Of Daily Change | 0.91 | |||
| Day Median Price | 1.64 | |||
| Day Typical Price | 1.61 | |||
| Price Action Indicator | (0.16) | |||
| Period Momentum Indicator | 0.34 |
Cue Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cue Biopharma's price direction in advance. Along with the technical and fundamental analysis of Cue Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cue to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.11) | |||
| Total Risk Alpha | (1.03) | |||
| Treynor Ratio | 0.1768 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cue Biopharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. For information on how to trade Cue Stock refer to our How to Trade Cue Stock guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Complementary Tools for Cue Stock analysis
When running Cue Biopharma's price analysis, check to measure Cue Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cue Biopharma is operating at the current time. Most of Cue Biopharma's value examination focuses on studying past and present price action to predict the probability of Cue Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cue Biopharma's price. Additionally, you may evaluate how the addition of Cue Biopharma to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |
Is Cue Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cue Biopharma. If investors know Cue will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cue Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.07) | Revenue Per Share 0.149 | Quarterly Revenue Growth 8.182 | Return On Assets (0.47) | Return On Equity (1.18) |
The market value of Cue Biopharma is measured differently than its book value, which is the value of Cue that is recorded on the company's balance sheet. Investors also form their own opinion of Cue Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Cue Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cue Biopharma's market value can be influenced by many factors that don't directly affect Cue Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cue Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cue Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cue Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.